Genmab A (GMAB) Current Taxes: 2018-2020

Historic Current Taxes for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to -$133.1 million.

  • Genmab A's Current Taxes rose 50.66% to -$52.72 in Q2 2021 from the same period last year, while for Jun 2021 it was -$52.72, marking a year-over-year increase of 50.66%. This contributed to the annual value of -$133.1 million for FY2020, which is 84.73% down from last year.
  • As of FY2020, Genmab A's Current Taxes stood at -$133.1 million, which was down 84.73% from -$72.1 million recorded in FY2019.
  • Genmab A's Current Taxes' 5-year high stood at -$15.5 million during FY2018, with a 5-year trough of -$133.1 million in FY2020.
  • Moreover, its 3-year median value for Current Taxes was -$72.1 million (2019), whereas its average is -$73.6 million.
  • Data for Genmab A's Current Taxes shows a maximum YoY crashed of 365.60% (in 2019) over the last 5 years.
  • Genmab A's Current Taxes (Yearly) stood at -$15.5 million in 2018, then tumbled by 365.60% to -$72.1 million in 2019, then crashed by 84.73% to -$133.1 million in 2020.